surmount-1 trial tirzepatide obesity without diabetes 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but diabetes. Researchers Tirzepatide's Surmount-4 Trial Reveals Groundbreaking

Drizzle with a light vinaigrette made from extra virgin olive oil and lemon juice

Today more and more women find that dealing with menopause symptoms is best accomplished via a combination of healthy lifestyle and alternative treatments

More than 40 drugmakers are expected to release over 50 generic versions, intensifying competition in one of the most lucrative healthcare markets

doi:10.1056/NEJMoa2511774

Correcting B12 changes your metabolism and nervous-system signalling, and that adjustment itself can feel like tiredness, lightheadedness or a vague off feeling before things settle

Kazmi Z, Fatima I, Perveen S, Malik SS